LILLY AUTHENTIC MEDICATION SHIPPED DIRECT
LIVE

Serial Number

98935419

Owner

Eli Lilly and Company

Attorney

Tiffany Trunko

Filing Date

Jan 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LILLY AUTHENTIC MEDICATION SHIPPED DIRECT Trademark

Serial Number: 98935419

LILLY AUTHENTIC MEDICATION SHIPPED DIRECT is a trademark filed by Eli Lilly and Company on January 3, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Eli Lilly and Company (90 trademarks)

Lilly Corporate Center
Indianapolis, IN 46285

Entity Type: 03

Trademark Details

Filing Date

January 3, 2025

Registration Date

Not Registered

Published for Opposition

May 27, 2025

Goods & Services

Retail pharmacy services; online retail pharmacy services; mail order pharmacy services; online retail store services featuring pharmaceuticals; online retail pharmacy services for the ordering, purchase, and delivery of pharmaceuticals; pharmaceutical services, namely, processing prescription orders

Healthcare services; medical services; telemedicine services; arranging and providing medical information services relating to pharmaceuticals, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Housemark for a full line of pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Filing History

SOU TEAS EXTENSION RECEIVED
Jul 2, 2026 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 3, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 3, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 3, 2026 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 17, 2025 EX1G
SOU EXTENSION 1 FILED
Dec 17, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 17, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 22, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 27, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 27, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 21, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 28, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 22, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 15, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 15, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 15, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 27, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 27, 2025 NWOS
NEW APPLICATION ENTERED
Jan 3, 2025 NWAP